Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

H7N9 Bird Flu Virus - Biotech, Pharma and Life Science Channel

10:33 EDT 19th April 2014 | BioPortfolio

Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. The avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses. Although some H7 viruses (H7N2, H7N3 and H7N7) have occasionally been found to infect humans, no human infections with H7N9 viruses have been reported until recent reports from China.

News Articles [11 Associated News Articles listed on BioPortfolio]

XTIO2 Self-Cleaning Global Travel Facemask with Record Year of Orders Features at the RAND Luxury Technology Event

International Self-Powered Building Council (ISPBC) showcased its world-exclusive self-cleaning XTIO2 GLOBAL Travel Facemask for travelers with the world’s highest protection: 1...

Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM)

GAITHERSBURG, Md., March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinan...

New TNO Triskelion Lab Tests Vaccines Against Deadly Viruses

ZEIST, The Netherlands, March 3, 2014 /PRNewswire/ -- Upgrade to BSL-3 level answers growing global demand for testing facilities Introduction of a Bio Safety Level 3 (BSL-3) facility and developmen...

New deadly strain of bird flu may have emerged

“Experts are concerned about the spread of a new strain of bird flu that has already killed one woman in China,” BBC News reports. The new strain, which has evolved from an existing bird flu vir...

Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

BEIJING, Jan. 29, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(...

NanoViricides Reports Construction of its New Facility and cGMP Pilot Production Plant is Nearing Completion, also Provides Details of its $20 Million Registered Direct Offering

NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company") reported today that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing...

Vivaldi Biosciences Signs Cooperative Research and Development Agreement (CRADA) with National Institute of Allergy and Infectious Diseases (NIAID) to Develop Live Attenuated Influenza Vaccine Against Influenza H7N9

Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines (LAIVs) against seasonal and pandemic influenza, today announ...

Meridian Bioscience Granted Special 510(k) Clearance for TRU FLU® to Add Avian H7N9 Influenza A Virus Analytical Sensitivity Claim

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that the company’s TRU FLU® assay received FDA clearance for an analytical sensitivity claim for the novel avian Influe...

Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus

PHILADELPHIA, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced publication of an article entitled "Emergence of a novel drug...

ATS Labs Offers Antimicrobial Testing Utilizing Avian Influenza A (H7N9) Virus

EAGAN, Minn., Dec. 6, 2013 /PRNewswire/ -- ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H...

Events [0 Results]


Companies [0 Results]


Clinical Trials [0 Results]


PubMed Articles [44 Associated PubMed Articles listed on BioPortfolio]

Experimental infection of dogs with H6N1 avian influenza A virus.

H6N1 avian influenza A viruses, which have spread across North America, Europe and Asia, have been shown to be infectious not only for birds but also for mammals. Because humans lack immunity to H6N1...

Development of a high yield live attenuated H7N9 influenza vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.

Live attenuated H7N9 influenza vaccine viruses that possess the hemagglutinin (HA) and neuraminidase (NA) gene segments from the newly emerged wild-type (wt) A/Anhui/1/2013 (H7N9) and six internal pro...

Airborne Transmission of Highly Pathogenic H7N1 Influenza in Ferrets.

Avian H7 influenza viruses are recognized as potential pandemic viruses as personnel often become infected during poultry outbreaks. H7 infections in humans typically cause mild conjunctivitis; howeve...

Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir.

To the Editor:In March 2013, a novel influenza A H7N9 virus of avian origin was reported to cause severe pneumonia in mainland China (1-3). While the great majority of patients were treated with oral...

Early response to the emergence of influenza A(H7N9) virus in humans in China: the central role of prompt information sharing and public communication.

In 2003, China's handling of the early stages of the epidemic of severe acute respiratory syndrome (SARS) was heavily criticized and generally considered to be suboptimal.

IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection.

Current influenza vaccines are ineffective against novel viruses and the source or the strain of the next outbreak of influenza is unpredictable; therefore, establishing universal immunity by vaccinat...

The limited number of available nucleotide and protein sequence data from the recent H7N9 cases in China impeded investigation and characterization of the outbreak.

The host protease TMPRSS2 plays a major role for in vivo replication of emerging H7N9 and seasonal influenza viruses.

Proteolytic cleavage of the hemagglutinin (HA) protein is essential for influenza A virus (IAV) to acquire infectivity. This process is mediated by a host cell protease(s) in vivo. The type II transme...

Laboratory diagnosis of avian influenza virus H7N9 infection in a renal transplant recipient.

A renal transplant recipient who had atypical clinical manifestations, unclear epidemiological exposure history and negative results from influenza virus antigen and nucleic acid amplification in thro...

Tannins from Hamamelis virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papillomavirus.

Antiviral activity has been demonstrated for different tannin-rich plant extracts. Since tannins of different classes and molecular weights are often found together in plant extracts and may differ in...

Medical and Biotech [MESH] Definitions

None available.

Search BioPortfolio:
review and buy H7N9 Bird Flu Virus market research data and corporate reports here

Channels Quicklinks